Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 3/20 | 0.43 |
| ▸ | MAOB | P27338 | 3/20 | 0.43 |
| ▸ | DRD4 | P21917 | 1/20 | 0.38 |
| ▸ | BRD4 | O60885 | 7/20 | 0.38 |
| ▸ | AKT1 | P31749 | 1/20 | 0.37 |
| ▸ | AKT2 | P31751 | 1/20 | 0.37 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.37 |
| ▸ | TYMS | P04818 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.34 |
| ▸ | TDP2 | O95551 | 1/20 | 0.33 |
| ▸ | NSD2 | O96028 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30109390 | 1.00 | KDM4E (0.45) | KDM4EALDH1A1HPGDGLAGAA | |
| SCHEMBL29396153 | 0.88 | BRD4 (0.47) | KDM4EALDH1A1HPGDMAOAMAOB | |
| SCHEMBL1274983 | 0.88 | BRD4 (0.47) | KDM4EALDH1A1HPGDMAOAMAOB | |
| SCHEMBL9579265 | 0.83 | MAOA (0.59) | KDM4EALDH1A1HPGDGLAGAA | |
| SCHEMBL15276007 | 0.83 | KDM4E (0.40) | KDM4EALDH1A1HPGDGLAGAA | |
| SCHEMBL23142108 | 0.83 | KDM4E (0.61) | KDM4EALDH1A1HPGDGLAGAA | |
| SCHEMBL18352941 | 0.83 | BRD4 (0.41) | KDM4EALDH1A1HPGDGLAGAA | |
| SCHEMBL30906133 | 0.83 | MAOA (0.46) | KDM4EALDH1A1HPGDGLAGAA | |
| SCHEMBL30067439 | 0.83 | KDM4E (0.40) | KDM4EALDH1A1HPGDGLAGAA | |
| SCHEMBL1275336 | 0.83 | MAOA (0.46) | KDM4EALDH1A1HPGDGLAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441748-B2 | Metal-ligand complexes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-10-14 | — | — | US | disclosed |
| US-20240368001-A1 | SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2024-11-07 | — | — | US | disclosed |
| US-11987506-B2 | Salt recovery solution and processes of use thereof | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2024-05-21 | — | — | US | disclosed |
| US-20230257284-A1 | SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2023-08-17 | — | — | US | disclosed |
| US-20230128137-A1 | BENZO FIVE-MEMBERED CYCLIC COMPOUND | MEDSHINE DISCOVERY INC. (CN) | 2023-04-27 | — | — | US | disclosed |
| CN-111225875-B | Salt recovery solution and method of using salt recovery solution | 阿克福特斯技术有限公司 | 2023-04-11 | — | — | CN | disclosed |
| US-20230043356-A1 | A SOLVENT DRYING COMPOSITION AND PROCESSES THEREFOR | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2023-02-09 | — | — | US | disclosed |
| CN-109715682-B | Polymerization catalyst | 尤尼威蒂恩技术有限责任公司 | 2022-09-30 | — | — | CN | disclosed |
| US-20220259231-A1 | METAL-LIGAND COMPLEXES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-08-18 | — | — | US | disclosed |
| EP-3519465-B1 | POLYMERIZATION CATALYSTS | UNIVATION TECH LLC (US) | 2022-06-29 | — | — | EP | disclosed |
| US-5708018-A | 2-aminoindans as selective dopamine D3 ligands | PHARMACIA & UPJOHN COMPANY (US) | 1998-01-13 | — | — | US | disclosed |
| EP-0712387-A1 | 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS | PHARMACIA & UPJOHN COMPANY (US) | 1996-05-22 | — | — | EP | disclosed |
| EP-0693506-A2 | Process for the preparation of amorphous polymers of propylene | SPHERILENE S.p.A. (IT) | 1996-01-24 | — | — | EP | disclosed |
| WO-1995004713-A1 | 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS | THE UPJOHN COMPANY (US) | 1995-02-16 | — | — | WO | disclosed |
| US-5110989-A | Pre- and postemergence; plant growth regulators | ICI AUSTRALIA LIMITED (AU) | 1992-05-05 | — | — | US | disclosed |
| US-4952722-A | CYCLOHEX-2-EN-1-ONE DERIVATIVES; HERBICIDES | ICI AUSTRALIA LIMITED (AU) | 1990-08-28 | — | — | US | disclosed |
| EP-0086588-B1 | CYCLOHEXANEDIONE DERIVATIVES, THEIR USE AS HERBICIDES, HERBICIDAL COMPOSITIONS CONTAINING THEM, AND METHODS OF PREPARING THEM | ICI AUSTRALIA LIMITED (AU) | 1987-07-01 | — | — | EP | disclosed |
| EP-0086588-A2 | Cyclohexanedione derivatives, their use as herbicides, herbicidal compositions containing them, and methods of preparing them | ICI AUSTRALIA LIMITED (AU) | 1983-08-24 | — | — | EP | disclosed |
| US-4076726-A | Amidino-hydrazone derivatives | AKZONA INCORPORATED (US) | 1978-02-28 | — | — | US | disclosed |
| US-4028380-A | Hydrazino-imidazole derivatives | AKZONA INCORPORATED (US) | 1977-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220259231-A1 | METAL-LIGAND COMPLEXES | ARL1, CRKL, SAAL1 | KDM4E 3747/4885ALDH1A1 4147/4885HPGD 4737/4885 |
| US-20230043356-A1 | A SOLVENT DRYING COMPOSITION AND PROCESSES THEREFOR | AQP1, AQP4, NOTUM | KDM4E 4279/4885ALDH1A1 3984/4885HPGD 904/4885 |
| US-20230128137-A1 | BENZO FIVE-MEMBERED CYCLIC COMPOUND | BCL2, BAX, BCL2L1 | KDM4E 1702/4885ALDH1A1 3365/4885HPGD 2484/4885 |
| US-12441748-B2 | Metal-ligand complexes | ARL1, CRKL, SAAL1 | KDM4E 3747/4885ALDH1A1 4147/4885HPGD 4737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.